A new generation of interactive formulation development platforms can leave trial and error in the formulation process in the past.
Jason Hansell
Advertisement
Jason Hansell is Junior Applications Technologist at Colorcon Inc. (PA, USA).
Articles by Jason Hansell
Based on formulation simplicity and blinding capability, hard gelatin capsules are preferrable compared with other oral solid dosage forms, including tablets, in the early clinical phases of drug development.
Advertisement
Latest Updated Articles
The New Digital Era for Formulation DevelopmentPublished: October 16th 2023 | Updated:
Narrowing the gap between clinical capsule formulations and commercial film-coated tabletsPublished: May 1st 2009 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
The Key Trends Driving Supply Chain Localization and Data Scrutiny in Biopharma
2
Excipient Innovation, Safer Solvents, and Supply Chain Resilience
3
Turning Real-World Data into Actionable Drug Development Insights With AI
4
The Bio/pharma Industry Navigates AI’s Impact on Workforce and Hiring
5
